Skip to main content

IQ Capital — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

202
Companies
$1.6B
Total invested
$15.2M
Avg. check
62
Industries
Artificial Intelligence (AI) 7Biotechnology 5Software 5Machine Learning 4Information Technology 4Education 3+56 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145168 of 202
Molyon
November 2024

Molyon designs next-generation high-energy-density batteries engineered for weight-critical applications.

Cambridge$4.5M Seed
Bhanzu
November 2024

Bhanzu is a math education platform that provides customized learning experience that addresses individual learning needs.

Apps · Hyderabad$16.5M Series B
Vsim Technology
September 2024

Vsim Technology offers physics simulations technologies for AI, robotics, VFX, research and the industrial metaverse.

Artificial Intelligence (AI) · Altrincham$21.5M Seed
CodePath
September 2024

CodePath is a nonprofit increasing diversity in tech by transforming CS college education.

Communities · San Francisco$50.0M Grant
NanoSyrinx
September 2024

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.

Biotechnology · Coventry$13.1M Series A
Opportunity@Work
July 2024

Opportunity@Work offers individual skill career opportunities, jobs and employment services.

Non Profit · Washington$20.0M Grant
Soul Machines
June 2024

Soul Machines is a pioneer in the humanization of AI. We create engaging, empathetic AI Assistants, powered by our patented Digital Brain™.

Artificial Intelligence (AI) · San Francisco$5.6M Convertible Note
Cheetah
March 2024

Cheetah is an e-commerce platform offering contactless pickup and delivery of food and supplies.

E-Commerce · San FranciscoSeries C
Zephyr AI
March 2024

Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.

Artificial Intelligence (AI) · Fairfax Station$111.0M Series A
Adaptive ML
March 2024

Adaptive ML is a technology firm that develops an LLM platform to help companies train and deploy language models using user feedback.

A/B Testing · Paris$20.0M Series A
Wobble Genomics
March 2024

Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

Biotechnology · Edinburgh$10.9M Seed
Baseimmune
February 2024

Baseimmune is a biotech startup founded to create the next generation of vaccines.

Biotechnology · London$11.4M Series A
FreeWorld
February 2024

FreeWorld invests in education for America's biggest underdogs and most overlooked talent pools - ex-felons.

Education · AustinGrant
MindRight Health
February 2024

MindRight Health offers culturally-responsive mental health coaching over a text message.

Health Care · NewarkGrant
Mytos
November 2023

Mytos is building a fully-automated cell manufacture platform for Pharma

Biotechnology · London$19.0M Series A
Quantum Diamonds
November 2023

Quantum Diamonds provides described nitrogen-vacancy diamonds for quantum sensing to industrial and academic customers.

3D Technology · Garching Bei München$7.7M Seed
Secretarium
September 2023

Secretarium is an integrity and confidentiality crypto-platform.

Information Services · LondonGrant
UnshETH
August 2023

UnshETH is a DeFi protocol that aims to reshape the landscape of Ethereum.

Blockchain · San Francisco$3.3M Seed
Nile
August 2023

Nile is an AI platform specializing in networking architecture and wired and wireless LAN services.

Artificial Intelligence (AI) · San Jose$175.0M Series C
Signaloid
May 2023

Signaloid provides hardware and cloud-based compute platforms for computing workloads ranging from robotics to quantitative finance

Artificial Intelligence (AI) · Cambridge$3.7M Seed
Builder.ai
May 2023

Builder.ai offers a no-code AI-powered app development platform designed to build and operate software projects.

Artificial Intelligence (AI) · London$250.0M Series D
Concirrus
March 2023

Concirrus support digital transformation of the specialty insurance industry using the latest developments in technology.

Consulting · LondonCorporate Round
CyberSmart
February 2023

An all-in-one cybersecurity monitoring, optimisation, training and insurance platform proven to defend SMBs against the unexpected.

B2B · London$15.3M Series B
Risilience
February 2023

Risilience is a climate-analytics technology platform that provides climate and enterprise risk management solutions.

Analytics · Cambridge$26.0M Series B

Where IQ Capital invests

Artificial Intelligence (AI)7
Biotechnology5
Software5
Machine Learning4
Information Technology4
Education3

About IQ Capital's portfolio

How many companies has IQ Capital invested in?

IQ Capital has invested in 202 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does IQ Capital invest in?

IQ Capital's top investment sectors include Artificial Intelligence (AI), Biotechnology, Software, Machine Learning, Information Technology. The firm invests across 62 different industry categories.

What is IQ Capital's largest investment?

Among tracked funding rounds, Builder.ai received $250.0M in a Series D round. IQ Capital's total known invested capital is $1.6B.

What is the average investment size for IQ Capital?

IQ Capital's average investment size is $15.2M across its portfolio of 202 companies.

What are IQ Capital's most recent investments?

Recent IQ Capital portfolio additions include Molyon, Bhanzu, Vsim Technology, CodePath, NanoSyrinx. These companies were founded in 2020 or later.

Reach the founders behind these 202 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →